Reason for request
Renewal of inclusion on the list of medicines refundable by National Health Insurance and Re-assessment of the actual benefit following the Transparency Committee conclusions in its opinions of 26 November 2008 and reiterated in its opinion of 21 September 2011.
Clinical Benefit
| Insufficient |
The actual benefit of CHONDROSULF 400 mg capsules and granules is insufficient to justify reimbursement by National Insurance. |
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
QquxaEpw75LUcbDm
